Please assess the completion status of the following clinical trial:

Trial Title: COPD Patients Diagnosed With GERD,COPD Exacerbations After Treatment With High Dose PPI

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* diagnosis of COPD~* forced expiratory volume/forced vital capacity ratio (FEV1/FVC) of \< 70% on pulmonary function testing~* age \> 40 years~* \>20 pack year history of smoking~Exclusion Criteria:~* presence of the following disorders: respiratory disorders other than COPD, known esophageal disease such as cancer, achalasia, stricture, active peptic ulcer disease, Zollinger-Ellison syndrome, mastocytosis, scleroderma, or current abuse of alcohol defined as greater than three alcoholic drinks per day.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- esomeprazole (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).